节点文献
可溶性B7-H3(sB7-H3)在急性白血病中的检测及临床意义
Detection and clinical significance of the soluble B7-H3 in acute leukemia
【摘要】 目的:检测sB7-H3在急性白血病病人脑脊液中的不同表达,以及分析该分子的表达与急性白血病的亚型的相关性。方法:采用ELISA的方法来检测sB7-H3在176位白血病病人脑脊液中的表达。依据国际公认的FAB(French-Amer-ican-British)分类系统将急性白血病病人分型。结果:sB7-H3在急性淋系白血病与急性髓系白血病中的表达差异显著(P=0.0381),这与人白血病细胞株的检测结果一致;在急性淋系白血病的亚型中,sB7-H3的表达没有显著性差异;在急性髓系白血病的亚型中,sB7-H3的表达在M3与M5和M4与M5之间存在显著性差异(分别为P=0.024 3和P=0.022 3)。结论:sB7-H3的表达与白血病的分型具有一定的相关性,同时也进一步证实B7-H3参与了人体免疫平衡的调节,可能会为今后急性白血病的临床诊断提供依据。
【Abstract】 Objective:To detect the different expression of soluble B7-H3(sB7-H3) in acute leukemia and analyze the association between the sB7-H3 level and the classification of acute leukemia.Methods:Enzyme-linked immunosorbent assay kits were used to measure the expression of sB7-H3 in cerebrospinal fluid(CSF) of 176 patients with acute leukemia.Classification of acute leukemia was accordance with the FAB(French-American-British) classification system.Results:There was signicant difference between acute lymphocyte leukemia(ALL) and acute myeloid leukemia(AML,P=0.038 1),which was the same as what in some human leukemia cell strains.However,there was no statistically signicant difference among the subtypes of ALL,but in the CSF of patients with AML,the level of sB7-H3 was significantly different between M3 and M5(P=0.024 3),M4 and M5(P=0.022 3).Conclusion:The level of sB7-H3 is associated with the classification of acute leukemia.B7-H3 has a role in the immune system balance.It may be useful in clinical diagnosis as a new technique.
- 【文献出处】 中国免疫学杂志 ,Chinese Journal of Immunology , 编辑部邮箱 ,2012年04期
- 【分类号】R733.7
- 【被引频次】8
- 【下载频次】105